In search of reliability in the description of gastroesophageal reflux disease (GERD)

Esophagus

Volumn 5, Issue 1, 2008, Pages 5-9

  Lambert, René ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Adenocarcinoma; Columnar metaplasia; Esophagitis; Gastroesiophageal reflux

Indexed keywords

BARRETT ESOPHAGUS; CANCER RISK; CARDIA CARCINOMA; CLINICAL EVALUATION; CLINICAL FEATURE; CONFERENCE PAPER; CONSENSUS; ENDOSCOPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS DISEASE; ESOPHAGUS METAPLASIA; ESOPHAGUS PH; ESOPHAGUS STENOSIS; ESOPHAGUS STRICTURE; EVIDENCE BASED MEDICINE; GASTROESOPHAGEAL REFLUX; GEOGRAPHIC DISTRIBUTION; HUMAN; IMPEDANCE; LOWER ESOPHAGUS SPHINCTER; MEDICAL LITERATURE; METAPLASIA; NONEROSIVE ESOPHAGEAL DISEASE; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; RELIABILITY; SCORING SYSTEM;

EID: 41849087365     PISSN: 16129059     EISSN: 16129067     Source Type: Journal    
DOI: 10.1007/s10388-007-0116-x     Document Type: Conference Paper

References (27)

1. El-Serag HB. Time trends of gastroesophageal reflux disease: a systematic review. Clin Gastroenterol Hepatol 2007;5:17-26.
2. Dent J, El-Serag HB, Wallander MA, Johansson S. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005;54:710-717.
3. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin N Am 2002;31:421-440.
4. Mishima I, Adachi K, Arima N, Amano K, Takashima T, Moritani M, et al. Prevalence of endoscopically negative and positive gastroesophageal reflux disease in the Japanese. Scand J Gastroenterol 2005;40:1005-1009.
5. Ulualp SO, Roland PS, Toohill RJ, Shaker R. Prevalence of gastroesophago-pharyngeal acid reflux events: an evidence-based systematic review. Am J Otolaryngol 2005;26:239-244.
6. Kouzu T, Hishikawa E, Watanabe Y, Inoue M, Satou T. Epidemiology of GERD in Japan (in Japanese). Nippon Rinsho 2007;65:791-794.
7. Wong BC, Kinoshita Y. Systematic review on epidemiology of gastroesophageal reflux disease in Asia. Clin Gastroenterol Hepatol 2006;4:398-407.
8. Goh KL. Changing epidemiology of gastroesophageal reflux disease in the Asian-Pacific region: an overview. J Gastroenterol Hepatol 2004;19(suppl 3):S22-S25.
9. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R; Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006;101:1900-1920.
10. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004;53(suppl 4):1-24.
11. Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999;45:172-180.
12. Anonymous. An evidence-based appraisal of reflux disease management: the Genval Workshop Report. Gut 1999;44(suppl 2): S1-16.
13. Fock KM, Talley N, Hunt R, Fass R, Nandurkar S, Lam SK, et al. Report of the Asia-Pacific consensus on the management of gastroesophageal reflux disease. J Gastroenterol Hepatol 2004;19:357-367.
14. Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998;7:75-83.
15. Tutuian R, Castell DO. Complete gastro-oesophageal reflux monitoring: combined pH and impedance. Aliment Pharmacol Ther 2006;24(suppl 2):27-37.
16. Sharma P, McQuaid K, Dent J, Fennerty MB, Sampliner R, Spechler S, et al. AGA Chicago Workshop. A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop. Gastroenterology 2004;127:310-330.
17. Sharma P. Review article: prevalence of Barrett's oesophagus and metaplasia at the gastro-oesophageal junction. Aliment Pharmacol Ther 2004;20(suppl 5):48-54.
18. Spechler SJ. Barrett's esophagus: an overrated cancer risk factor. Gastroenterology 2000;119(2):587-589.
19. Shaheen NJ, Crosby MA, Bozymski EM, Sandler RS. Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 2000;119:333-338.
20. Sharma P, Dent J, Armstrong D, Bergman JJ, Gossner L, Hoshihara Y, et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006;131:1392-1399.
21. No authors listed. Paris Workshop on Columnar Metaplasia in the Esophagus and the Esophagogastric Junction, Paris, France, December 11-12, 2004. Endoscopy 2005;37:879-920.
22. Edebo A, Tam W, Bruno M, Van Berkel AM, Jönson C, Schoeman M, et al. Magnification endoscopy for diagnosis of nonerosive reflux disease: a proposal of diagnostic criteria and critical analysis of observer variability. Endoscopy 2007;39:195-201.
23. Lee CH, Wu DC, Lee JM, Wu IC, Goan YG, Kao EL, Huang HL, et al. Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. Eur J Cancer 2007;43:1188-1199.
24. Lambert R, Hainaut P. Esophageal cancer: II. The precursors. Endoscopy 2007;39:659-664.
25. Lambert R, Hainaut P. Esophageal cancer: I. Cases and causes. Endoscopy 2007;39:550-555.
26. Lambert R, Hainaut P, Parkin DM. Premalignant lesions of the esophagogastric mucosa. Semin Oncol 2004;31:498-512.
27. Vakil N. Review article: The role of surgery in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2007;25:1365-1372.